ACV Auctions heads into its August 5 earnings report with the stock up 22% in a month and options positioning at its most aggressively bullish in over a year — a sharp reversal from the cautious stance that defined most of Q2.
The clearest shift is in the options market. The put/call ratio has collapsed to 0.16, nearly three standard deviations below its 20-day average of 0.45. That makes it the most call-heavy reading in over a year, with the PCR 52-week low sitting at just 0.02. The reversal is striking: for most of June and early July, the PCR held steadily above 0.50, reflecting genuine hedging demand. In the space of two weeks, that has unwound completely. Call buyers are now firmly in control of the options flow, suggesting market participants are positioning for the rally to continue into the print rather than protecting against a pullback.
Short interest adds a layer of complexity. At 9.4% of the free float — around 16.2 million shares — the short book is meaningful but is actively retreating. It has fallen roughly 9.6% over the past month, down from a peak near 18 million shares in late June. That decline has coincided directly with the stock's re-rating. Importantly, borrow conditions remain loose: availability runs near 994%, meaning roughly ten shares are available in the lending pool for every one currently borrowed. Cost to borrow is 0.31%, up 30% on the week but still in low-single-digits — no squeeze mechanics in sight. Shorts have room to rebuild if the earnings catalyst disappoints, and covering pressure is not what's driving this rally.
The Street picture is mixed but tilting cautiously positive. Barclays raised its target to $8 from $7 on July 22, though the Equal-Weight rating signals limited conviction. Goldman Sachs holds a Buy with a $10 target — though that target was set in February after being cut from $13, so some staleness applies. B. Riley's $16 target looks out of step with where the stock and consensus sit. The mean analyst target of $9.43 implies roughly 19% upside from $7.93. Factor scores tell a two-speed story: EPS momentum is exceptional, ranking in the 83rd and 91st percentiles over 30 and 90 days respectively. Yet the EPS surprise rank sits at just the 6th percentile, and the short score rank of 17 reflects a stock that screens as relatively pressured on short-interest metrics despite the recent improvement.
Institutional positioning shows some active buying beneath the surface. Vanguard Capital Management and Vanguard Portfolio Management each appear to have initiated positions as of March 31, together adding roughly 14.4 million shares. UBS Asset Management added 3.1 million shares in the same period. BlackRock added a more modest 564,000 shares through June 30. The offset is Atreides Management, which trimmed 2.7 million shares through Q1. On the insider side, a coordinated cluster of sales on July 1 — covering the CEO, CFO, COO, CLO, and Chief Accounting Officer — totalled roughly $370,000 at $7.29 per share. Individual amounts are small and likely reflect scheduled plan sales rather than conviction selling, but the timing is worth noting against the backdrop of the subsequent price jump.
Earnings history offers a useful reference point. The Q1 2026 result on May 6 delivered a 20% single-day gain. The most recent prior print in late May produced a more modest 5.7% move. With Q2 results due August 5, the pattern is asymmetric — ACVA has shown it can re-rate sharply on a positive surprise. The bull case centres on digital wholesale adoption, guaranteed pricing traction, and commercial market expansion. Bears point to competitive pressure and sensitivity to used-vehicle pricing dynamics, both of which remain active risks. Close peers CPRT and RBA each slipped about 1% on the week while ACVA gained nearly 10%, widening the performance gap and suggesting this is a stock-specific move rather than a sector bid.
With the PCR near its annual low, shorts pulling back but not exhausted, and a high-beta earnings history, the August 5 print is the only number that matters now — whether the call-heavy positioning reflects a well-informed bet or a setup for disappointment.
See the live data behind this article on ORTEX.
Open ACVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
